Posttransplant recipient-derived CD4⁺ T-cell lymphoproliferative disease in X-linked hyper-IgM syndrome

Pediatr Blood Cancer. 2019 Mar;66(3):e27529. doi: 10.1002/pbc.27529. Epub 2018 Oct 30.

Authors

Yasuaki Hagio¹, Akira Shiraishi¹, Masataka Ishimura¹, Motoshi Sonoda¹, Katsuhide Eguchi¹, Hidetaka Yamamoto², Yoshinao Oda², Shouichi Ohga¹

Affiliations

¹ Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
² Department of Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

PMID: 30378267
DOI: 10.1002/pbc.27529

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Bone Marrow Transplantation / adverse effects*
CD4-Positive T-Lymphocytes / immunology
CD4-Positive T-Lymphocytes / metabolism
CD4-Positive T-Lymphocytes / pathology*
CD40 Ligand / genetics
CD40 Ligand / metabolism
Humans
Hyper-IgM Immunodeficiency Syndrome, Type 1 / pathology
Hyper-IgM Immunodeficiency Syndrome, Type 1 / therapy*
Infant
Lymphoproliferative Disorders / diagnosis
Lymphoproliferative Disorders / etiology*
Male
Prognosis

Substances

CD40 Ligand